Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

VU0422288

🥰Excellent
Catalog No. T29135Cas No. 1630936-95-6
Alias VU-0422288, VU 0422288, ML-396, ML396, ML 396

VU0422288 (ML396) is a potent orthosteric modulator of type III mGlu receptors (mGlus).VU0422288 shows inhibition of mGluR4, mGluR7, and mGluR8 in a calcium mobilization assay.VU0422288 can be used to study Rett syndrome (RTT).

VU0422288

VU0422288

🥰Excellent
Purity: 95.48%
Catalog No. T29135Alias VU-0422288, VU 0422288, ML-396, ML396, ML 396Cas No. 1630936-95-6
VU0422288 (ML396) is a potent orthosteric modulator of type III mGlu receptors (mGlus).VU0422288 shows inhibition of mGluR4, mGluR7, and mGluR8 in a calcium mobilization assay.VU0422288 can be used to study Rett syndrome (RTT).
Pack SizePriceAvailabilityQuantity
5 mg$73In Stock
10 mg$123In Stock
25 mg$247In Stock
50 mg$396In Stock
100 mg$645In Stock
500 mg$1,330In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "VU0422288"

Select Batch
Purity:95.48%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
VU0422288 (ML396) is a potent orthosteric modulator of type III mGlu receptors (mGlus).VU0422288 shows inhibition of mGluR4, mGluR7, and mGluR8 in a calcium mobilization assay.VU0422288 can be used to study Rett syndrome (RTT).
Targets&IC50
mGluR7:146 nM (EC50), mGluR8:128 nM (EC50), mGluR4:108 nM (EC50)
In vitro
In coronal slices containing the hippocampus, VU0422288 (1 μM; 5 minutes) enhances the reduction in slope of the field excitatory postsynaptic potentials (fEPSPs) induced by 30 μM LSP4-2022[1].However, when administered alone for 10 minutes at a concentration of 1 μM, VU0422288 does not alter the slope of fEPSP, indicating that under stimulation conditions, mGlu7 does not possess reinforcing activity in Mecp2-/y slices[1].
In vivo
In Mecp2+/- mice, VU0422288 (30 mg/kg; intraperitoneal injection; once daily for 17 days) rescues synaptic plasticity deficits and learning-memory phenotypes, reduces the frequency of respiratory pause, while showing no effect in Mecp2+/+ animals[1].
A single dose of VU0422288 (10 mg/kg; intraperitoneal injection) in adult male Sprague-Dawley rats exhibits a plasma/brain partition coefficient of 1.67, predicting a free brain concentration of approximately 40 nM[1].
AliasVU-0422288, VU 0422288, ML-396, ML396, ML 396
Chemical Properties
Molecular Weight360.19
FormulaC17H11Cl2N3O2
Cas No.1630936-95-6
SmilesClc1ccc(Oc2ccc(NC(=O)c3ccccn3)cc2Cl)nc1
Relative Density.1.445 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 3.6 mg/mL (10 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7763 mL13.8816 mL27.7631 mL138.8156 mL
5 mM0.5553 mL2.7763 mL5.5526 mL27.7631 mL
10 mM0.2776 mL1.3882 mL2.7763 mL13.8816 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy VU0422288 | purchase VU0422288 | VU0422288 cost | order VU0422288 | VU0422288 chemical structure | VU0422288 in vivo | VU0422288 in vitro | VU0422288 formula | VU0422288 molecular weight